Ruminations on the future of pharmacovigilance – new podcast out now

Perspective / 15 December 2022

After the pandemic: what were the lessons learnt for pharmacovigilance? Find out in the latest episode of the Drug Safety Matters podcast.


COVID-19 forced pharmacovigilance experts to revisit their processes to deal with unprecedented volumes of data and catch unexpected safety issues.

Elena Rocca of Oslo Metropolitan University joins Drug Safety Matters host Federica Santoro in the studio for a philosophical inquiry into the lessons to be learnt from the pandemic – and what it can teach us about the science of drug safety.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

Risk is in the eye of the beholder when it comes to communication

What’s trending in pharmacovigilance? New podcast episode

Risk Communications in Healthcare – Bridging the Gap

You may also like

Risk Communications in Healthcare – Bridging the Gap

Effective risk communication is a mainstay of successful pharmacovigilance, yet examples of poor risk mitigation abound. Where are we failing, and what can be done about it?

20 November 2023

Risk is in the eye of the beholder when it comes to communication

Are you and your patient talking about the same thing when you discuss risk? Most likely not, and understanding this is key to effective risk communication.

18 March 2024

What’s trending in pharmacovigilance? New podcast episode

In this festive edition of Drug Safety Matters, we wrap up the year that was and look ahead to the year that will be – with a little help from one of our friends.

21 December 2023